Early stage diagnosis of gastric cancer by plasma microRNA and tumor-free DNA
Project/Area Number |
17K10608
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Teikyo University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
飯沼 久恵 帝京大学, 医学部, 講師 (30147102)
|
Project Period (FY) |
2017-04-01 – 2022-03-31
|
Project Status |
Completed (Fiscal Year 2021)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2019: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2018: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 胃癌 / PDL-1 / PDL-2 / 予後 / バイオマーカー / 免疫チェックポイント阻害薬 / 免疫療法 / リキッドバイオプシー / PD-L1 / PD-L2 / microRNA / 腹膜播種 / エクソソーム / 再発予測 / 予後予測 / free-DNA |
Outline of Final Research Achievements |
The prognosis of gastric cancer (GC) patients with advanced stage is still poor. Nivolumab has been used for metastatic GC in Japan from 2017 as an immunotherapeutic agent. Nivolumab can block the binding between PD-1 of lymphocyte and PD-L1/PD-L2 of tumor cell. However, the prognostic predicting role of PD-L1/PD-L2 expression is not clear. Thus, the aim of this investigation was to look at the correlation between the PD-L1/PD-L2 and clinicopathological factors of GC patients. The expression of PD-L1/PD-L2 in the serum and tumor tissue of 242 GC patients who underwent surgery were analyzed. The expressions of PD-L1/PD-L2 in the serum were higher than those of normal control. There was no significant correlation between the expression of PD-L1/PD-L2 in the serum and tumor tissue of gastric cancer patients and clinicopathological factors and of patients’ survival. It is concluded that the expression of PD-L1/PD-L2 in gastric cancer patients was not estimated as prognostic factor.
|
Academic Significance and Societal Importance of the Research Achievements |
ニボルマブをはじめとする免疫チェックポイント阻害薬の発展は、癌治療におけるブレイクスルーでゲームチェンジャーとなりうる。したがって、関連分野の研究は今後ますますその重要性が増すものと考えられる。PD-L1/PD-L2は、ニボルマブの作用点に関連する分子である。今回の検討では、PD-L1/PD-L2発現は胃癌の臨床病理学的因子、生存率との関連を認めなかったが、この発現の詳細を検討することは、今後の免疫チェックポイント阻害薬治療発展の一助になるものと考えられる。
|
Report
(6 results)
Research Products
(113 results)
-
-
[Journal Article] QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study2021
Author(s)
Ito Y, Fujitani K, Sakamaki K, Ando M, Kawabata R, Tanizawa Y, Yoshikawa T, Yamada T, Hirao M, Yamada M, Hihara J, Fukushima R, Choda Y, Kodera Y, Teshima S, Shinohara H, Kondo M
-
Journal Title
Gastric Cancer
Volume: 24
Issue: 5
Pages: 1131-1139
DOI
NAID
Related Report
Peer Reviewed
-
[Journal Article] Comparison of effects of six main gastrectomy procedures on patients' quality of life assessed by Postgastrectomy Syndrome Assessment Scale-452021
Author(s)
Nakada K, Kawashima Y, Kinami S, Fukushima R, Yabusaki H, Seshimo A, Hiki N, Koeda K, Kano M, Uenosono Y, Oshio A, Kodera Y
-
Journal Title
World J Gastrointest Surg
Volume: 13
Issue: 5
Pages: 461-475
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer.2019
Author(s)
Soeda N, Iinuma H, Suzuki Y, Tsukahara D, Midorikawa H, Igarashi Y, Kumata Y, Horikawa M, Kiyokawa T, Fukagawa T, Fukushima R
-
Journal Title
ONCOLOGY LETTERS
Volume: 18
Pages: 4467-4480
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community.2019
Author(s)
Jensen GL, Cederholm T, Correia M, Gonzalez MC, Fukushima R, Higashiguchi T, de Baptista GA, Barazzoni R, Blaauw R, Coats AJS, et al
-
Journal Title
JPEN J Parenter Enteral Nutr
Volume: 43
Issue: 1
Pages: 32-40
DOI
Related Report
Peer Reviewed
-
[Journal Article] GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community.2019
Author(s)
Cederholm T, Jensen GL, Correia M, Gonzalez MC, Fukushima R, Higashiguchi T, Baptista G, Barazzoni R, Blaauw R, Coats AJS, et al
-
Journal Title
J Cachexia Sarcopenia Muscle
Volume: 10
Issue: 1
Pages: 207-217
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Effect of early oral feeding on length of hospital stay following gastrectomy for gastric cancer: a Japanese multicenter, randomized controlled trial.2018
Author(s)
Shimizu N, Oki E, Tanizawa Y, Suzuki Y, Aikou S, Kunisaki C, Tsuchiya T, Fukushima R, Doki Y, Natsugoe S, et al
-
Journal Title
Surg Today
Volume: 48
Issue: 9
Pages: 865-874
DOI
Related Report
Peer Reviewed
-
[Journal Article] A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II).2018
Author(s)
Nishikawa K, Tsuburaya A, Yoshikawa T, Kobayashi M, Kawada J, Fukushima R, Matsui T, Tanabe K, Yamaguchi K, Yoshino S, et al
-
Journal Title
Eur J Cancer
Volume: 101
Pages: 220-228
DOI
Related Report
Peer Reviewed
-
[Journal Article] The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C).2018
Author(s)
Nishikawa K, Aoyama T, Oba MS, Yoshikawa T, Matsuda C, Munemoto Y, Takiguchi N, Tanabe K, Nagata N, Imano M, et al
-
Journal Title
J Cancer
Volume: 9
Issue: 10
Pages: 1725-1730
DOI
Related Report
Peer Reviewed
-
[Journal Article] Factors Influencing Cancer Patients' Choice of End-of Life Care Place.2018
Author(s)
Natsume M, Watanabe K, Matsumoto S, Naruge D, Hayashi K, Furuse J, Kawamura M, Jinno H, Sano K, Fukushima R, Osawa G, Aruga E, Hashiguchi Y, Tanaka A, Takikawa H, Seki N.
-
Journal Title
Journal of palliative mediceine
Volume: Epub ahead of print
Issue: 6
Pages: 751-765
DOI
Related Report
Peer Reviewed
-
[Journal Article] Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.2018
Author(s)
Ishigami H, Fujiwara Y, Fukushima R, Nashimoto A, Yabusaki H, Imano M, Imamoto H, Kodera Y, Uenosono Y, Amagai K, et al
-
Journal Title
J Clin Oncol
Volume: 36
Issue: 19
Pages: 1922-1929
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
[Journal Article] Randomized clinical trial of 24 versus 72 h antimicrobial prophylaxis in patients undergoing open total gastrectomy for gastric cancer.2017
Author(s)
Takagane A, Mohri Y, Konishi T, Fukushima R, Noie T, Sueyoshi S, Omura K, Ono S, Kusunoki M, Mochizuki H, Sumiyama Y
-
Journal Title
Br J Surg
Volume: 104
Issue: 2
Pages: e158-e164
DOI
Related Report
Peer Reviewed
-
[Journal Article] Health insurance or subsidy has universal advantage for management of hospital malnutrition unrelated to GDP.2017
Author(s)
Klek S, Chourdakis M, Abosaleh DA, Amestoy A, Baik HW, Baptista G, Barazzoni R, Fukushima R, Hartono J, Jayawardena R, et al
-
Journal Title
Asia Pac J Clin Nutr
Volume: 26
Pages: 247-254
Related Report
Peer Reviewed
-
-
[Journal Article] Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer2017
Author(s)
Takano Y, Masuda T, Iinuma H, Yamaguchi R, Sato K, Tobo T, Hirata H, Kuroda Y, Nambara S, Hayashi N, Iguchi T, Ito S, Eguchi H, Ochiya T, Yanaga K, Miyano S, Mimori K
-
Journal Title
Oncotarget
Volume: 8(45)
Issue: 45
Pages: 78598-78613
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] Does lung cancer surgery cause circulating tumor cells?-A multicenter, prospective study.2017
Author(s)
Matsutani N, Sawabata N, Yamaguchi M, Woo T, Kudo Y, Kawase A, Shiono S, Iinuma H, Morita S, Kawamura M.
-
Journal Title
J Thorac Dis.
Volume: 9(8)
Issue: 8
Pages: 2419-2426
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
[Presentation] 胃切除術後障害を考えた栄養管理 胃切除術が術後患者の日常生活に及ぼす影響について PGSASスタディの知見から2021
Author(s)
中田 浩二, 高橋 正純, 福島 亮治, 吉田 昌, 池田 正視, 木南 伸一, 上之園 芳一, 小寺 泰弘, 國崎 主税, 薮崎 裕, 山下 裕玄, 瀬戸 泰之
Organizer
第36回日本臨床栄養代謝学会
Related Report
-
-
[Presentation] 胃癌腹膜播種に対する全身・腹腔内投与併用化学療法奏効後のConversion Surgeryの治療成績(英語)2021
Author(s)
有上 貴明, 石神 浩徳, 大森 健, 小寺 泰弘, 藪崎 裕, 福島 亮治, 今野 元博, 伊藤 誠二, 富田 寿彦, 秀村 晃生, 上之園 芳一, 天貝 賢二, 太田 光彦, 岸 健太郎, 北山 丈二
Organizer
第121回日本外科学会定期学術集会
Related Report
-
[Presentation] 4型胃癌に対する補助化学療法としての腹腔内・全身併用化学療法の意義を検証する無作為化第III相試験 PHOENIX-GC2 trial(英語)2021
Author(s)
伊藤 誠二, 石神 浩徳, 山下 裕玄, 小寺 泰弘, 今野 元博, 福島 亮治, 深川 剛生, 藪崎 裕, 北山 丈二, 山口 博紀, 辻 靖, 秀村 晃生, 島田 英昭, 太田 光彦, 廣野 靖夫, 大庭 幸治, 瀬戸 泰之
Organizer
第121回日本外科学会定期学術集会
Related Report
-
-
-
[Presentation] 包括的な胃がん外科治療の構築2020
Author(s)
深川 剛生, 堀川 昌宏, 清川 貴志, 添田 成美, 熊田 宜真, 鈴木 悠介, 緑川 裕紀, 五十嵐 裕一, 金城 信哉, 藤條 開, 福島 亮治
Organizer
板橋区医師会
Related Report
-
-
[Presentation] 腹膜播種陽性胃癌に対する経静脈・腹腔内併用化学療法 10余年間の成果2020
Author(s)
蜂谷 修, 石神 浩徳, 大森 健, 小寺 泰弘, 藪崎 裕, 福島 亮治, 今野 元博, 門脇 重憲, 富田 寿彦, 秀村 晃生, 有上 貴明, 廣野 靖夫, 辻 靖, 楠本 哲也, 北山 丈二
Organizer
日本癌治療学会学術集会抄録集58回
Related Report
-
[Presentation] 4型胃癌に対する術後/周術期化学療法としての腹腔内化学療法を検証する第III相試験2020
Author(s)
石神 浩徳, 山下 裕玄, 小寺 泰弘, 今野 元博, 福島 亮治, 深川 剛生, 藪崎 裕, 伊藤 誠二, 北山 丈二, 山口 博紀, 瀬戸 泰之
Organizer
日本癌治療学会学術集会抄録集58回
Related Report
-
-
[Presentation] 腹膜播種を伴う胃癌に対する全身・腹腔内投与併用化学療法の治療成績2020
Author(s)
太田 光彦, 石神 浩徳, 小寺 泰弘, 小林 大介, 福島 亮治, 深川 剛生, 門脇 重憲, 秀村 晃生, 竹野 淳, 吉川 幸造, 山口 博紀, 北山 丈二
Organizer
日本臨床外科学会
Related Report
-
[Presentation] 腹膜播種を伴う進行胃癌症例に対する腹腔内投与を伴う全身化学療法後の外科手術の成績2020
Author(s)
深川 剛生, 石神 浩徳, 大森 健, 小寺 泰弘, 藪崎 裕, 福島 亮治, 今野 元博, 三澤 一成, 富田 寿彦, 秀村 晃生, 有上 貴明, 天貝 賢二, 辻 靖, 楠本 哲也, 岸 健太郎, 上田 修吾, 伏田 幸夫, 今村 和弘, 緒方 杏一,
Organizer
第120回日本外科学会定期学術集会
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] 胃癌の早期再発予測および予後予測に有用な血漿エクソソーム内包microRNAの検討2018
Author(s)
熊田 宜真, 飯沼 久恵, 田村 純子, 緑川 裕紀, 鈴木 悠介, 塚原 大裕, 五十嵐 裕一, 添田 成美, 堀川 昌宏, 清川 貴志, 深川 剛生, 福島 亮治
Organizer
第39回癌免疫外科研究会
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Phase II study of ip PTX+S-1/PTX for gastric cancer with positive peritoneal cytology.2018
Author(s)
Imano M, Ishigami H, Yabusaki H, Imamoto H, Yamashita H, Kishi K, Kodera Y, Uenosono Y, Fujiwara Y, Hidemura A, Tamura S, Fukushima R, Yamaguchi, Kitayam J
Organizer
第90回日本胃癌学会総会
Related Report
-
-
-
-
-
[Presentation] Phase II study of intraperitoneal docetaxel plus capecitabine/cisplatin for gastric cancer with peritoneal metastasis: XP+IP DOC trial.2017
Author(s)
Ryoji Fukushima, Hironori Ishigami, Hiroto Miwa, Motohiro Imano, Daisuke Kobayashi, Yasushi Tsuji, Akio Hidemura, Tetsuya Kusumoto, Takeshi Omori, Hiroshi Yabusaki, Norifumi Ohashi, Mitsuhiko Ota, Hironori Yamaguchi, Joji Kitayama
Organizer
American Society for Clinical Oncology
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-